APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nanopore Molecular Sequencing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nanopore Molecular Sequencing Service Market Outlook and Growth Opportunities 2026

4 June 2026213 pages

Choose your research edition.

Industry ResearchNanopore Molecular Sequencing Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanopore Molecular Sequencing Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Nanopore Molecular Sequencing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanopore Molecular Sequencing Service Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanopore Molecular Sequencing Service Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Nanopore Molecular Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nanopore Molecular Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nanopore Molecular Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nanopore Molecular Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nanopore Molecular Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nanopore Molecular Sequencing Service market include Azenta Life Sciences, Novogene Co., Ltd., BGI Genomics Co., Ltd., Eurofins Genomics, Plasmidsaurus, Biomarker Technologies Corporation, Macrogen Inc., CD Genomics and Microsynth AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Nanopore Molecular Sequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nanopore Molecular Sequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nanopore Molecular Sequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nanopore Molecular Sequencing Service market.

Nanopore Molecular Sequencing Service Segment by Company

Azenta Life Sciences

Novogene Co., Ltd.

BGI Genomics Co., Ltd.

Eurofins Genomics

Plasmidsaurus

Biomarker Technologies Corporation

Macrogen Inc.

CD Genomics

Microsynth AG

BaseClear

Genotypic Technology Pvt. Ltd.

Takara Bio Inc.

FASMAC Co., Ltd.

SeqCenter

SeqCoast Genomics

Wuhan Benagen Tech Co., Ltd.

GenoScreen

IGA Technology

MicrobesNG

Source BioScience

GenXone

PathoSense

AllGenetics

BIOTOOLS Co., Ltd.

GeneBay, Inc.

Seibutsugiken Co., Ltd.

Biofidus

KeyGene

LongSeq Applications

Nanopore Molecular Sequencing Service Segment by Type

Direct DNA Sequencing

Direct RNA Sequencing

cDNA Sequencing (RNA→cDNA)

DNA+RNA Combined Sequencing

Nanopore Molecular Sequencing Service Segment by Application

Life Sciences

Clinical Medicine

Biomedicine

Public Health

Other

Nanopore Molecular Sequencing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nanopore Molecular Sequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nanopore Molecular Sequencing Service key companies, revenue, market share, and recent developments.

3. To split the Nanopore Molecular Sequencing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nanopore Molecular Sequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nanopore Molecular Sequencing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Nanopore Molecular Sequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanopore Molecular Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanopore Molecular Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanopore Molecular Sequencing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nanopore Molecular Sequencing Service industry.

Chapter 3: Detailed analysis of Nanopore Molecular Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nanopore Molecular Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nanopore Molecular Sequencing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nanopore Molecular Sequencing Service Industry Trends Table 2. Nanopore Molecular Sequencing Service Industry Drivers Table 3. Nanopore Molecular Sequencing Service Industry Opportunities and Challenges Table 4. Nanopore Molecular Sequencing Service Industry Restraints Table 5. Global Nanopore Molecular Sequencing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nanopore Molecular Sequencing Service Revenue Share by Company (2021-2026) Table 7. Global Nanopore Molecular Sequencing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nanopore Molecular Sequencing Service Key Company Manufacturing Base & Headquarters Table 9. Global Nanopore Molecular Sequencing Service Company, Product Type & Application Table 10. Global Nanopore Molecular Sequencing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nanopore Molecular Sequencing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Direct DNA Sequencing Table 15. Significant Companies of Direct RNA Sequencing Table 16. Significant Companies of cDNA Sequencing (RNA→cDNA) Table 17. Significant Companies of DNA+RNA Combined Sequencing Table 18. Global Nanopore Molecular Sequencing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Nanopore Molecular Sequencing Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Nanopore Molecular Sequencing Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Nanopore Molecular Sequencing Service Sales Value Share by Type (2021-2026) Table 22. Global Nanopore Molecular Sequencing Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Life Sciences Table 24. Significant Companies of Clinical Medicine Table 25. Significant Companies of Biomedicine Table 26. Significant Companies of Public Health Table 27. Significant Companies of Other Table 28. Global Nanopore Molecular Sequencing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Nanopore Molecular Sequencing Service Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Nanopore Molecular Sequencing Service Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Nanopore Molecular Sequencing Service Sales Value Share by Application (2021-2026) Table 32. Global Nanopore Molecular Sequencing Service Sales Value Share by Application (2027-2032) Table 33. Global Nanopore Molecular Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Nanopore Molecular Sequencing Service Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Nanopore Molecular Sequencing Service Sales Value Share by Region (2021-2026) Table 36. Global Nanopore Molecular Sequencing Service Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Nanopore Molecular Sequencing Service Sales Value Share by Region (2027-2032) Table 38. Global Nanopore Molecular Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Nanopore Molecular Sequencing Service Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Nanopore Molecular Sequencing Service Sales Value Market Share by Country (2021-2026) Table 41. Global Nanopore Molecular Sequencing Service Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Nanopore Molecular Sequencing Service Sales Value Market Share by Country (2027-2032) Table 43. Azenta Life Sciences Company Information Table 44. Azenta Life Sciences Business Overview Table 45. Azenta Life Sciences Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Azenta Life Sciences Nanopore Molecular Sequencing Service Product Portfolio Table 47. Azenta Life Sciences Recent Development Table 48. Novogene Co., Ltd. Company Information Table 49. Novogene Co., Ltd. Business Overview Table 50. Novogene Co., Ltd. Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Novogene Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 52. Novogene Co., Ltd. Recent Development Table 53. BGI Genomics Co., Ltd. Company Information Table 54. BGI Genomics Co., Ltd. Business Overview Table 55. BGI Genomics Co., Ltd. Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. BGI Genomics Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 57. BGI Genomics Co., Ltd. Recent Development Table 58. Eurofins Genomics Company Information Table 59. Eurofins Genomics Business Overview Table 60. Eurofins Genomics Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Eurofins Genomics Nanopore Molecular Sequencing Service Product Portfolio Table 62. Eurofins Genomics Recent Development Table 63. Plasmidsaurus Company Information Table 64. Plasmidsaurus Business Overview Table 65. Plasmidsaurus Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Plasmidsaurus Nanopore Molecular Sequencing Service Product Portfolio Table 67. Plasmidsaurus Recent Development Table 68. Biomarker Technologies Corporation Company Information Table 69. Biomarker Technologies Corporation Business Overview Table 70. Biomarker Technologies Corporation Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Biomarker Technologies Corporation Nanopore Molecular Sequencing Service Product Portfolio Table 72. Biomarker Technologies Corporation Recent Development Table 73. Macrogen Inc. Company Information Table 74. Macrogen Inc. Business Overview Table 75. Macrogen Inc. Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Macrogen Inc. Nanopore Molecular Sequencing Service Product Portfolio Table 77. Macrogen Inc. Recent Development Table 78. CD Genomics Company Information Table 79. CD Genomics Business Overview Table 80. CD Genomics Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. CD Genomics Nanopore Molecular Sequencing Service Product Portfolio Table 82. CD Genomics Recent Development Table 83. Microsynth AG Company Information Table 84. Microsynth AG Business Overview Table 85. Microsynth AG Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Microsynth AG Nanopore Molecular Sequencing Service Product Portfolio Table 87. Microsynth AG Recent Development Table 88. BaseClear Company Information Table 89. BaseClear Business Overview Table 90. BaseClear Nanopore Molecular Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. BaseClear Nanopore Molecular Sequencing Service Product Portfolio Table 92. BaseClear Recent Development Table 93. Genotypic Technology Pvt. Ltd. Company Information Table 94. Genotypic Technology Pvt. Ltd. Business Overview Table 95. Genotypic Technology Pvt. Ltd. Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Genotypic Technology Pvt. Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 97. Genotypic Technology Pvt. Ltd. Recent Development Table 98. Takara Bio Inc. Company Information Table 99. Takara Bio Inc. Business Overview Table 100. Takara Bio Inc. Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Takara Bio Inc. Nanopore Molecular Sequencing Service Product Portfolio Table 102. Takara Bio Inc. Recent Development Table 103. FASMAC Co., Ltd. Company Information Table 104. FASMAC Co., Ltd. Business Overview Table 105. FASMAC Co., Ltd. Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. FASMAC Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 107. FASMAC Co., Ltd. Recent Development Table 108. SeqCenter Company Information Table 109. SeqCenter Business Overview Table 110. SeqCenter Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. SeqCenter Nanopore Molecular Sequencing Service Product Portfolio Table 112. SeqCenter Recent Development Table 113. SeqCoast Genomics Company Information Table 114. SeqCoast Genomics Business Overview Table 115. SeqCoast Genomics Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. SeqCoast Genomics Nanopore Molecular Sequencing Service Product Portfolio Table 117. SeqCoast Genomics Recent Development Table 118. Wuhan Benagen Tech Co., Ltd. Company Information Table 119. Wuhan Benagen Tech Co., Ltd. Business Overview Table 120. Wuhan Benagen Tech Co., Ltd. Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Wuhan Benagen Tech Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 122. Wuhan Benagen Tech Co., Ltd. Recent Development Table 123. GenoScreen Company Information Table 124. GenoScreen Business Overview Table 125. GenoScreen Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. GenoScreen Nanopore Molecular Sequencing Service Product Portfolio Table 127. GenoScreen Recent Development Table 128. IGA Technology Company Information Table 129. IGA Technology Business Overview Table 130. IGA Technology Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. IGA Technology Nanopore Molecular Sequencing Service Product Portfolio Table 132. IGA Technology Recent Development Table 133. MicrobesNG Company Information Table 134. MicrobesNG Business Overview Table 135. MicrobesNG Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. MicrobesNG Nanopore Molecular Sequencing Service Product Portfolio Table 137. MicrobesNG Recent Development Table 138. Source BioScience Company Information Table 139. Source BioScience Business Overview Table 140. Source BioScience Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Source BioScience Nanopore Molecular Sequencing Service Product Portfolio Table 142. Source BioScience Recent Development Table 143. GenXone Company Information Table 144. GenXone Business Overview Table 145. GenXone Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. GenXone Nanopore Molecular Sequencing Service Product Portfolio Table 147. GenXone Recent Development Table 148. PathoSense Company Information Table 149. PathoSense Business Overview Table 150. PathoSense Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. PathoSense Nanopore Molecular Sequencing Service Product Portfolio Table 152. PathoSense Recent Development Table 153. AllGenetics Company Information Table 154. AllGenetics Business Overview Table 155. AllGenetics Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. AllGenetics Nanopore Molecular Sequencing Service Product Portfolio Table 157. AllGenetics Recent Development Table 158. BIOTOOLS Co., Ltd. Company Information Table 159. BIOTOOLS Co., Ltd. Business Overview Table 160. BIOTOOLS Co., Ltd. Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. BIOTOOLS Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 162. BIOTOOLS Co., Ltd. Recent Development Table 163. GeneBay, Inc. Company Information Table 164. GeneBay, Inc. Business Overview Table 165. GeneBay, Inc. Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. GeneBay, Inc. Nanopore Molecular Sequencing Service Product Portfolio Table 167. GeneBay, Inc. Recent Development Table 168. Seibutsugiken Co., Ltd. Company Information Table 169. Seibutsugiken Co., Ltd. Business Overview Table 170. Seibutsugiken Co., Ltd. Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. Seibutsugiken Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio Table 172. Seibutsugiken Co., Ltd. Recent Development Table 173. Biofidus Company Information Table 174. Biofidus Business Overview Table 175. Biofidus Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 176. Biofidus Nanopore Molecular Sequencing Service Product Portfolio Table 177. Biofidus Recent Development Table 178. KeyGene Company Information Table 179. KeyGene Business Overview Table 180. KeyGene Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 181. KeyGene Nanopore Molecular Sequencing Service Product Portfolio Table 182. KeyGene Recent Development Table 183. LongSeq Applications Company Information Table 184. LongSeq Applications Business Overview Table 185. LongSeq Applications Nanopore Molecular Sequencing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 186. LongSeq Applications Nanopore Molecular Sequencing Service Product Portfolio Table 187. LongSeq Applications Recent Development Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Nanopore Molecular Sequencing Service Product Image Figure 2. Global Nanopore Molecular Sequencing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nanopore Molecular Sequencing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Nanopore Molecular Sequencing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Direct DNA Sequencing Image Figure 8. Direct RNA Sequencing Image Figure 9. cDNA Sequencing (RNA→cDNA) Image Figure 10. DNA+RNA Combined Sequencing Image Figure 11. Global Nanopore Molecular Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Nanopore Molecular Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Nanopore Molecular Sequencing Service Sales Value Share by Type (2021-2032) Figure 14. Life Sciences Image Figure 15. Clinical Medicine Image Figure 16. Biomedicine Image Figure 17. Public Health Image Figure 18. Other Image Figure 19. Global Nanopore Molecular Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Nanopore Molecular Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Nanopore Molecular Sequencing Service Sales Value Share by Application (2021-2032) Figure 22. Global Nanopore Molecular Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Nanopore Molecular Sequencing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Nanopore Molecular Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 25. North America Nanopore Molecular Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Nanopore Molecular Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Nanopore Molecular Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Nanopore Molecular Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Nanopore Molecular Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Nanopore Molecular Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 31. South America Nanopore Molecular Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Nanopore Molecular Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Nanopore Molecular Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Direct DNA Sequencing
  • Direct RNA Sequencing
  • cDNA Sequencing (RNA→cDNA)
  • DNA+RNA Combined Sequencing
Applications
  • Life Sciences
  • Clinical Medicine
  • Biomedicine
  • Public Health
  • Other
Companies covered
  • Azenta Life Sciences
  • Novogene Co., Ltd.
  • BGI Genomics Co., Ltd.
  • Eurofins Genomics
  • Plasmidsaurus
  • Biomarker Technologies Corporation
  • Macrogen Inc.
  • CD Genomics
  • Microsynth AG
  • BaseClear
  • Genotypic Technology Pvt. Ltd.
  • Takara Bio Inc.
  • FASMAC Co., Ltd.
  • SeqCenter
  • SeqCoast Genomics
  • Wuhan Benagen Tech Co., Ltd.
  • GenoScreen
  • IGA Technology
  • MicrobesNG
  • Source BioScience
  • GenXone
  • PathoSense
  • AllGenetics
  • BIOTOOLS Co., Ltd.
  • GeneBay, Inc.
  • Seibutsugiken Co., Ltd.
  • Biofidus
  • KeyGene
  • LongSeq Applications

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nanopore Molecular Sequencing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nanopore Molecular Sequencing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nanopore Molecular Sequencing Service Market Dynamics
  1. 2.1 Nanopore Molecular Sequencing Service Industry Trends
  2. 2.2 Nanopore Molecular Sequencing Service Industry Drivers
  3. 2.3 Nanopore Molecular Sequencing Service Industry Opportunities and Challenges
  4. 2.4 Nanopore Molecular Sequencing Service Industry Restraints
3 Nanopore Molecular Sequencing Service Market by Company
  1. 3.1 Global Nanopore Molecular Sequencing Service Company Revenue Ranking in 2025
  2. 3.2 Global Nanopore Molecular Sequencing Service Revenue by Company (2021-2026)
  3. 3.3 Global Nanopore Molecular Sequencing Service Company Ranking (2024-2026)
  4. 3.4 Global Nanopore Molecular Sequencing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Nanopore Molecular Sequencing Service Company Product Type and Application
  6. 3.6 Global Nanopore Molecular Sequencing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nanopore Molecular Sequencing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nanopore Molecular Sequencing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nanopore Molecular Sequencing Service Market by Type
  1. 4.1 Nanopore Molecular Sequencing Service Type Introduction
  2. 4.1.1 Direct DNA Sequencing
  3. 4.1.2 Direct RNA Sequencing
  4. 4.1.3 cDNA Sequencing (RNA→cDNA)
  5. 4.1.4 DNA+RNA Combined Sequencing
  6. 4.2 Global Nanopore Molecular Sequencing Service Sales Value by Type
  7. 4.2.1 Global Nanopore Molecular Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Nanopore Molecular Sequencing Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Nanopore Molecular Sequencing Service Sales Value Share by Type (2021-2032)
5 Nanopore Molecular Sequencing Service Market by Application
  1. 5.1 Nanopore Molecular Sequencing Service Application Introduction
  2. 5.1.1 Life Sciences
  3. 5.1.2 Clinical Medicine
  4. 5.1.3 Biomedicine
  5. 5.1.4 Public Health
  6. 5.1.5 Other
  7. 5.2 Global Nanopore Molecular Sequencing Service Sales Value by Application
  8. 5.2.1 Global Nanopore Molecular Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Nanopore Molecular Sequencing Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Nanopore Molecular Sequencing Service Sales Value Share by Application (2021-2032)
6 Nanopore Molecular Sequencing Service Regional Value Analysis
  1. 6.1 Global Nanopore Molecular Sequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nanopore Molecular Sequencing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nanopore Molecular Sequencing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nanopore Molecular Sequencing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nanopore Molecular Sequencing Service Sales Value (2021-2032)
  7. 6.3.2 North America Nanopore Molecular Sequencing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nanopore Molecular Sequencing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Nanopore Molecular Sequencing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nanopore Molecular Sequencing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nanopore Molecular Sequencing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nanopore Molecular Sequencing Service Sales Value (2021-2032)
  16. 6.6.2 South America Nanopore Molecular Sequencing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nanopore Molecular Sequencing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nanopore Molecular Sequencing Service Sales Value Share by Country, 2025 VS 2032
7 Nanopore Molecular Sequencing Service Country-level Value Analysis
  1. 7.1 Global Nanopore Molecular Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nanopore Molecular Sequencing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nanopore Molecular Sequencing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nanopore Molecular Sequencing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nanopore Molecular Sequencing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nanopore Molecular Sequencing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nanopore Molecular Sequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Azenta Life Sciences
  2. 8.1.1 Azenta Life Sciences Company Information
  3. 8.1.2 Azenta Life Sciences Business Overview
  4. 8.1.3 Azenta Life Sciences Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Azenta Life Sciences Nanopore Molecular Sequencing Service Product Portfolio
  6. 8.1.5 Azenta Life Sciences Recent Developments
  7. 8.2 Novogene Co., Ltd.
  8. 8.2.1 Novogene Co., Ltd. Company Information
  9. 8.2.2 Novogene Co., Ltd. Business Overview
  10. 8.2.3 Novogene Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novogene Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  12. 8.2.5 Novogene Co., Ltd. Recent Developments
  13. 8.3 BGI Genomics Co., Ltd.
  14. 8.3.1 BGI Genomics Co., Ltd. Company Information
  15. 8.3.2 BGI Genomics Co., Ltd. Business Overview
  16. 8.3.3 BGI Genomics Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BGI Genomics Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  18. 8.3.5 BGI Genomics Co., Ltd. Recent Developments
  19. 8.4 Eurofins Genomics
  20. 8.4.1 Eurofins Genomics Company Information
  21. 8.4.2 Eurofins Genomics Business Overview
  22. 8.4.3 Eurofins Genomics Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eurofins Genomics Nanopore Molecular Sequencing Service Product Portfolio
  24. 8.4.5 Eurofins Genomics Recent Developments
  25. 8.5 Plasmidsaurus
  26. 8.5.1 Plasmidsaurus Company Information
  27. 8.5.2 Plasmidsaurus Business Overview
  28. 8.5.3 Plasmidsaurus Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Plasmidsaurus Nanopore Molecular Sequencing Service Product Portfolio
  30. 8.5.5 Plasmidsaurus Recent Developments
  31. 8.6 Biomarker Technologies Corporation
  32. 8.6.1 Biomarker Technologies Corporation Company Information
  33. 8.6.2 Biomarker Technologies Corporation Business Overview
  34. 8.6.3 Biomarker Technologies Corporation Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biomarker Technologies Corporation Nanopore Molecular Sequencing Service Product Portfolio
  36. 8.6.5 Biomarker Technologies Corporation Recent Developments
  37. 8.7 Macrogen Inc.
  38. 8.7.1 Macrogen Inc. Company Information
  39. 8.7.2 Macrogen Inc. Business Overview
  40. 8.7.3 Macrogen Inc. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Macrogen Inc. Nanopore Molecular Sequencing Service Product Portfolio
  42. 8.7.5 Macrogen Inc. Recent Developments
  43. 8.8 CD Genomics
  44. 8.8.1 CD Genomics Company Information
  45. 8.8.2 CD Genomics Business Overview
  46. 8.8.3 CD Genomics Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CD Genomics Nanopore Molecular Sequencing Service Product Portfolio
  48. 8.8.5 CD Genomics Recent Developments
  49. 8.9 Microsynth AG
  50. 8.9.1 Microsynth AG Company Information
  51. 8.9.2 Microsynth AG Business Overview
  52. 8.9.3 Microsynth AG Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Microsynth AG Nanopore Molecular Sequencing Service Product Portfolio
  54. 8.9.5 Microsynth AG Recent Developments
  55. 8.10 BaseClear
  56. 8.10.1 BaseClear Company Information
  57. 8.10.2 BaseClear Business Overview
  58. 8.10.3 BaseClear Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BaseClear Nanopore Molecular Sequencing Service Product Portfolio
  60. 8.10.5 BaseClear Recent Developments
  61. 8.11 Genotypic Technology Pvt. Ltd.
  62. 8.11.1 Genotypic Technology Pvt. Ltd. Company Information
  63. 8.11.2 Genotypic Technology Pvt. Ltd. Business Overview
  64. 8.11.3 Genotypic Technology Pvt. Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Genotypic Technology Pvt. Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  66. 8.11.5 Genotypic Technology Pvt. Ltd. Recent Developments
  67. 8.12 Takara Bio Inc.
  68. 8.12.1 Takara Bio Inc. Company Information
  69. 8.12.2 Takara Bio Inc. Business Overview
  70. 8.12.3 Takara Bio Inc. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Takara Bio Inc. Nanopore Molecular Sequencing Service Product Portfolio
  72. 8.12.5 Takara Bio Inc. Recent Developments
  73. 8.13 FASMAC Co., Ltd.
  74. 8.13.1 FASMAC Co., Ltd. Company Information
  75. 8.13.2 FASMAC Co., Ltd. Business Overview
  76. 8.13.3 FASMAC Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 FASMAC Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  78. 8.13.5 FASMAC Co., Ltd. Recent Developments
  79. 8.14 SeqCenter
  80. 8.14.1 SeqCenter Company Information
  81. 8.14.2 SeqCenter Business Overview
  82. 8.14.3 SeqCenter Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SeqCenter Nanopore Molecular Sequencing Service Product Portfolio
  84. 8.14.5 SeqCenter Recent Developments
  85. 8.15 SeqCoast Genomics
  86. 8.15.1 SeqCoast Genomics Company Information
  87. 8.15.2 SeqCoast Genomics Business Overview
  88. 8.15.3 SeqCoast Genomics Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 SeqCoast Genomics Nanopore Molecular Sequencing Service Product Portfolio
  90. 8.15.5 SeqCoast Genomics Recent Developments
  91. 8.16 Wuhan Benagen Tech Co., Ltd.
  92. 8.16.1 Wuhan Benagen Tech Co., Ltd. Company Information
  93. 8.16.2 Wuhan Benagen Tech Co., Ltd. Business Overview
  94. 8.16.3 Wuhan Benagen Tech Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Wuhan Benagen Tech Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  96. 8.16.5 Wuhan Benagen Tech Co., Ltd. Recent Developments
  97. 8.17 GenoScreen
  98. 8.17.1 GenoScreen Company Information
  99. 8.17.2 GenoScreen Business Overview
  100. 8.17.3 GenoScreen Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 GenoScreen Nanopore Molecular Sequencing Service Product Portfolio
  102. 8.17.5 GenoScreen Recent Developments
  103. 8.18 IGA Technology
  104. 8.18.1 IGA Technology Company Information
  105. 8.18.2 IGA Technology Business Overview
  106. 8.18.3 IGA Technology Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 IGA Technology Nanopore Molecular Sequencing Service Product Portfolio
  108. 8.18.5 IGA Technology Recent Developments
  109. 8.19 MicrobesNG
  110. 8.19.1 MicrobesNG Company Information
  111. 8.19.2 MicrobesNG Business Overview
  112. 8.19.3 MicrobesNG Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 MicrobesNG Nanopore Molecular Sequencing Service Product Portfolio
  114. 8.19.5 MicrobesNG Recent Developments
  115. 8.20 Source BioScience
  116. 8.20.1 Source BioScience Company Information
  117. 8.20.2 Source BioScience Business Overview
  118. 8.20.3 Source BioScience Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Source BioScience Nanopore Molecular Sequencing Service Product Portfolio
  120. 8.20.5 Source BioScience Recent Developments
  121. 8.21 GenXone
  122. 8.21.1 GenXone Company Information
  123. 8.21.2 GenXone Business Overview
  124. 8.21.3 GenXone Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 GenXone Nanopore Molecular Sequencing Service Product Portfolio
  126. 8.21.5 GenXone Recent Developments
  127. 8.22 PathoSense
  128. 8.22.1 PathoSense Company Information
  129. 8.22.2 PathoSense Business Overview
  130. 8.22.3 PathoSense Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 PathoSense Nanopore Molecular Sequencing Service Product Portfolio
  132. 8.22.5 PathoSense Recent Developments
  133. 8.23 AllGenetics
  134. 8.23.1 AllGenetics Company Information
  135. 8.23.2 AllGenetics Business Overview
  136. 8.23.3 AllGenetics Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 AllGenetics Nanopore Molecular Sequencing Service Product Portfolio
  138. 8.23.5 AllGenetics Recent Developments
  139. 8.24 BIOTOOLS Co., Ltd.
  140. 8.24.1 BIOTOOLS Co., Ltd. Company Information
  141. 8.24.2 BIOTOOLS Co., Ltd. Business Overview
  142. 8.24.3 BIOTOOLS Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 BIOTOOLS Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  144. 8.24.5 BIOTOOLS Co., Ltd. Recent Developments
  145. 8.25 GeneBay, Inc.
  146. 8.25.1 GeneBay, Inc. Company Information
  147. 8.25.2 GeneBay, Inc. Business Overview
  148. 8.25.3 GeneBay, Inc. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  149. 8.25.4 GeneBay, Inc. Nanopore Molecular Sequencing Service Product Portfolio
  150. 8.25.5 GeneBay, Inc. Recent Developments
  151. 8.26 Seibutsugiken Co., Ltd.
  152. 8.26.1 Seibutsugiken Co., Ltd. Company Information
  153. 8.26.2 Seibutsugiken Co., Ltd. Business Overview
  154. 8.26.3 Seibutsugiken Co., Ltd. Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Seibutsugiken Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
  156. 8.26.5 Seibutsugiken Co., Ltd. Recent Developments
  157. 8.27 Biofidus
  158. 8.27.1 Biofidus Company Information
  159. 8.27.2 Biofidus Business Overview
  160. 8.27.3 Biofidus Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Biofidus Nanopore Molecular Sequencing Service Product Portfolio
  162. 8.27.5 Biofidus Recent Developments
  163. 8.28 KeyGene
  164. 8.28.1 KeyGene Company Information
  165. 8.28.2 KeyGene Business Overview
  166. 8.28.3 KeyGene Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  167. 8.28.4 KeyGene Nanopore Molecular Sequencing Service Product Portfolio
  168. 8.28.5 KeyGene Recent Developments
  169. 8.29 LongSeq Applications
  170. 8.29.1 LongSeq Applications Company Information
  171. 8.29.2 LongSeq Applications Business Overview
  172. 8.29.3 LongSeq Applications Nanopore Molecular Sequencing Service Revenue and Gross Margin (2021-2026)
  173. 8.29.4 LongSeq Applications Nanopore Molecular Sequencing Service Product Portfolio
  174. 8.29.5 LongSeq Applications Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst